Strategy

The demand for behavioral health services continues to rise, yet providers face challenges that hinder care.

Across society, mental and behavioral health issues are all too[...]

Whether at the individual, provider, or health system level, the[...]

If it can be said that a small ray of light came from the global COVID-19 pandemic, it may be that some inroads were made into changing the way we provide medication access in behavioral healthcare.

Did you know that hospitalization costs due specifically to antipsychotic nonadherence have been estimated at $1.5 billion annually?

In general, anyone entering a healthcare facility goes in with the goal of getting well and going home. Between staffing shortages, a rise in behavioral health diagnoses, and a shortage of hospital beds, something has to change.

Medication adherence plays a crucial role in behavioral health. For individuals grappling with mental health conditions adhering to prescriptions is vital for achieving positive outcomes.

In a world with hybrid cars, jobs, banks, cameras, and even airplanes, it is no surprise that “hybrid” has become a buzzword in behavioral health.

Access to affordable medications is a critical issue in the United States. As many as 18 million Americans reported being unable to afford needed prescriptions. Cost barriers can have a significant impact on their health and well-being.

Like much of healthcare, pharmacy has seen many changes in recent decades, including buyouts and mergers. As a result of the industry consolidation, only a small handful of pharmacy organizations take in the majority of drug revenue.